FindTrial
Sign In

A study on drug resistance of Helicobacter pylori

A study on drug resistance of Helicobacter pylori

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066900
Enrollment
Unknown
Registered
2022-12-21
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Observation group:N/A

Sponsors

Nanfang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Subjects who voluntarily sign informed consent; (2) Age range from 18 to 75 years old, regardless of gender; (3) The subject intends to undergo gastroscopy; (4) The DOB value of the subject's C13 breath test is positive;

Exclusion criteria

Exclusion criteria: (1) Subjects who are unable to complete gastroscopy or have contraindications to gastroscopy; (2) subjects considered unsuitable for the clinical study by the investigator; (3) Subjects enrolled in other clinical studies within 30 days prior to enrollment;

Design outcomes

Primary

MeasureTime frame
the mutation sites of 23SrRNA and gyrA mutant genes of helicobacter pylori;—

Countries

China

Contacts

Public ContactWang Xinke

Nanfang Hospital of Southern Medical University

wangxk07@smu.edu.cn15626432307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026